LivaNova PLC LIVN
79.90 USD -0.31 (-0.39%)
At closeNov 3, 2026, 4:01 PM EST
79.90 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
79.56 Day range 81.87
48.82 52-week range 85.76
- YTD
- +29.86%
- 1 year
- +51.96%
Analyst view
Consensus: buy
Buy
Price target (mean) 90.55 +13.3% upside
Now 79.90
- Target (low)
- 75.00
- Target (mean)
- 90.55
- Target (high)
- 105.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
- Strong buy3
- Buy6
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 10
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.06 | 1.02 – 1.13 | 1.11 | -4.6% | 381.11M | +6.5% | 10 |
| Next quarter | 1.06 | 1.03 – 1.10 | 0.86 | +22.7% | 390.24M | +8.1% | 10 |
| Current year | 4.36 | 4.32 – 4.40 | 3.90 | +11.7% | 1.52B | +9.6% | 10 |
| Next year | 4.68 | 4.46 – 4.93 | 4.36 | +7.5% | 1.63B | +7.1% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Sep 2, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Aug 5, 2026 | Needham | Maintained | Buy | Buy |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 1, 2026 | Freedom Capital Markets | Initiated | — | Hold |
| Jun 22, 2026 | Keybanc | Maintained | Overweight | Overweight |
| May 7, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 7, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 7, 2026 | Baird | Maintained | Outperform | Outperform |
| Feb 27, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Jan 9, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jan 7, 2026 | Stifel | Maintained | Buy | Buy |
| Dec 19, 2025 | Keybanc | Initiated | — | Overweight |
| Dec 17, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 13, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 13, 2025 | Baird | Maintained | Outperform | Outperform |
| Nov 6, 2025 | Baird | Maintained | Outperform | Outperform |
| Sep 3, 2025 | Needham | Reiterated | Buy | Buy |
| Aug 21, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 20, 2025 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| May 13, 2025 | Needham | Reiterated | Buy | Buy |
| May 8, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2025 | Baird | Maintained | Outperform | Outperform |
| Mar 17, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 7, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Mar 3, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 26, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Feb 26, 2025 | Stifel | Maintained | Buy | Buy |
| Feb 26, 2025 | Needham | Maintained | Buy | Buy |